A new personalized mRNA melanoma vaccine developed by Moderna and Merck is showing promising results, cutting the risk of cancer recurrence nearly in half for high-risk patients.

On February 2, 2026, U.S. District Court for the Eastern District of Pennsylvania Judge Joshua D. Wolson, sitting by designation in the U.S.

On February 2, 2026, U.S. District Judge Joshua D. Wolson made several key summary judgment rulings in advance of trial in ...

Some periods of history are so bizarre that even if you’ve lived through them, looking back on them feels surreal, as though ...

A world-first trial in Australia will treat children with advanced brain cancer using technology from the COVID-19 jab.

Australia has launched the world’s first clinical trial testing personalized mRNA cancer vaccines in children suffering from ...

University of Oklahoma researchers have created a new drug delivery system that helps cancer cells take in much more of a ...

RNA technologies have rapidly evolved into one of the most exciting and versatile classes of modern medicines, powering ...

AT HIS NOMINATION hearing in January 2025, Robert F. Kennedy Jr. announced he’d “do everything in my power to put the health ...

National Institutes of Health (NIH) Director Jayanta Bhattacharya, M.D., Ph.D., spent much of a Senate committee hearing dancing around direct answers—except when it came to vaccines, a topic in which ...

A tiny sea creature may have cracked the code to eternal youth, and scientists just found the cells that could make it ...